Day One released end of trial data, our dipg will be interim. That said with no approved dipg drugs and having fast track if the data on 20+ patients demonstrates significant dfp at 6 months we may get to lodge an nda. Fingers crossed, tho if the data is good you'd hope that Day One add it to their portfolio of kids cancer drugs.
- Forums
- ASX - By Stock
- KZA
- Comparisions other Drug Companies
Comparisions other Drug Companies, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)